Marijuana Reconsidered [Paperback]

Grinspoon (Author)

Editorial Reviews

From Publishers Weekly

This new edition of Harvard Medical School professor Grinspoon's 1971 study of the medical, social and legal aspects of pot use features a new introduction by the author.

Copyright 1994 Cahners Business Information, Inc.

Product Details

• Paperback: 496 pages
• Publisher: Quick American Archives; 2nd edition (March 30, 1994)
• Language: English
• ISBN-10: 0932551130
• ISBN-13: 978-0932551139
• Product Dimensions: 8.7 x 6 x 1.1 inches
• Shipping Weight: 1.4 pounds
• Average Customer Review: 4.6 out of 5 stars  See all reviews (7 customer reviews)
• Amazon Best Sellers Rank: #953,671 in Books (See Top 100 in Books)

More About the Author

Discover books, learn about writers, read author blogs, and more.

Most Helpful Customer Reviews

11 of 12 people found the following review helpful

4.0 out of 5 stars But who is Mr. X? October 16, 1999

By K Cycloid

Format:Paperback

For what it's worth, one interesting thing about this book is that the essay by Mr. X has been positively attributed to the luminant Carl Sagan by Grinspoon himself. Sagan discusses his experiences with mj, and provides persuasive and convincing accounts of his experiences. Very interesting.

9 of 10 people found the following review helpful

4.0 out of 5 stars A thorough and exhaustive evaluation of marijuana February 20, 1998

By A Customer

Format:Paperback

Dr. Grinspoon examines - and thoroughly debunks - many of the common misconceptions about marijuana. The Chemistry and Pharmacology chapter is rather heavy going, but it can be ignored with little loss by non-pharmacologists. I thoght the book was quite well done and useful in understanding the role, past and present, of marijuana in society.

10 of 13 people found the following review helpful

4.0 out of 5 stars A thorough examination of the use of cannabinoids in medicin June 13, 1997

By A Customer

Format:Paperback

Dr Grinspoon is one of the World's leading
authorities on medicinal uses of cannabis. He
makes a good case for the re-introduction of
cannabis to mitigate symptoms of many conditions.

Unfortunately, drugs must be thoroughly tested,
which costs millions. No pharmaceutical company
will fund testing of a herb you can grow on your
window sill for free :-(